Cargando…

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines

BACKGROUND: Alphaviral replicon-based vectors induce potent immune responses both when given as viral particles (VREP) or as DNA (DREP). It has been suggested that the strong immune stimulatory effect induced by these types of vectors is mediated by induction of danger signals and activation of inna...

Descripción completa

Detalles Bibliográficos
Autores principales: Näslund, Tanja I, Kostic, Linda, Nordström, Eva KL, Chen, Margaret, Liljeström, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038947/
https://www.ncbi.nlm.nih.gov/pubmed/21261958
http://dx.doi.org/10.1186/1743-422X-8-36
_version_ 1782198149973016576
author Näslund, Tanja I
Kostic, Linda
Nordström, Eva KL
Chen, Margaret
Liljeström, Peter
author_facet Näslund, Tanja I
Kostic, Linda
Nordström, Eva KL
Chen, Margaret
Liljeström, Peter
author_sort Näslund, Tanja I
collection PubMed
description BACKGROUND: Alphaviral replicon-based vectors induce potent immune responses both when given as viral particles (VREP) or as DNA (DREP). It has been suggested that the strong immune stimulatory effect induced by these types of vectors is mediated by induction of danger signals and activation of innate signalling pathways due to the replicase activity. To investigate the innate signalling pathways involved, mice deficient in either toll-like receptors or downstream innate signalling molecules were immunized with DREP or VREP. RESULTS: We show that the induction of a CD8(+ )T cell response did not require functional TLR3 or MyD88 signalling. However, IRF3, converging several innate signalling pathways and important for generation of pro-inflammatory cytokines and type I IFNs, was needed for obtaining a robust primary immune response. Interestingly, type I interferon (IFN), induced by most innate signalling pathways, had a suppressing effect on both the primary and memory T cell responses after DREP and VREP immunization. CONCLUSIONS: We show that alphaviral replicon-based vectors activate multiple innate signalling pathways, which both activate and restrict the induced immune response. These results further show that there is a delicate balance in the strength of innate signalling and induction of adaptive immune responses that should be taken into consideration when innate signalling molecules, such as type I IFNs, are used as vaccine adjuvant.
format Text
id pubmed-3038947
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30389472011-02-15 Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines Näslund, Tanja I Kostic, Linda Nordström, Eva KL Chen, Margaret Liljeström, Peter Virol J Research BACKGROUND: Alphaviral replicon-based vectors induce potent immune responses both when given as viral particles (VREP) or as DNA (DREP). It has been suggested that the strong immune stimulatory effect induced by these types of vectors is mediated by induction of danger signals and activation of innate signalling pathways due to the replicase activity. To investigate the innate signalling pathways involved, mice deficient in either toll-like receptors or downstream innate signalling molecules were immunized with DREP or VREP. RESULTS: We show that the induction of a CD8(+ )T cell response did not require functional TLR3 or MyD88 signalling. However, IRF3, converging several innate signalling pathways and important for generation of pro-inflammatory cytokines and type I IFNs, was needed for obtaining a robust primary immune response. Interestingly, type I interferon (IFN), induced by most innate signalling pathways, had a suppressing effect on both the primary and memory T cell responses after DREP and VREP immunization. CONCLUSIONS: We show that alphaviral replicon-based vectors activate multiple innate signalling pathways, which both activate and restrict the induced immune response. These results further show that there is a delicate balance in the strength of innate signalling and induction of adaptive immune responses that should be taken into consideration when innate signalling molecules, such as type I IFNs, are used as vaccine adjuvant. BioMed Central 2011-01-24 /pmc/articles/PMC3038947/ /pubmed/21261958 http://dx.doi.org/10.1186/1743-422X-8-36 Text en Copyright ©2011 Näslund et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Näslund, Tanja I
Kostic, Linda
Nordström, Eva KL
Chen, Margaret
Liljeström, Peter
Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
title Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
title_full Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
title_fullStr Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
title_full_unstemmed Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
title_short Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
title_sort role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038947/
https://www.ncbi.nlm.nih.gov/pubmed/21261958
http://dx.doi.org/10.1186/1743-422X-8-36
work_keys_str_mv AT naslundtanjai roleofinnatesignallingpathwaysintheimmunogenicityofalphaviralrepliconbasedvaccines
AT kosticlinda roleofinnatesignallingpathwaysintheimmunogenicityofalphaviralrepliconbasedvaccines
AT nordstromevakl roleofinnatesignallingpathwaysintheimmunogenicityofalphaviralrepliconbasedvaccines
AT chenmargaret roleofinnatesignallingpathwaysintheimmunogenicityofalphaviralrepliconbasedvaccines
AT liljestrompeter roleofinnatesignallingpathwaysintheimmunogenicityofalphaviralrepliconbasedvaccines